Insider Transactions in Q4 2023 at Arcutis Biotherapeutics, Inc. (ARQT)
Insider Transaction List (Q4 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 20
2023
|
Todd Franklin Watanabe Director |
BUY
Bona fide gift
|
Indirect |
13,126
+21.19%
|
-
|
|
Dec 20
2023
|
Todd Franklin Watanabe Director |
SELL
Bona fide gift
|
Direct |
13,126
-1.28%
|
-
|
|
Dec 01
2023
|
Todd Franklin Watanabe Director |
BUY
Exercise of conversion of derivative security
|
Direct |
59,525
+10.38%
|
$59,525
$1.68 P/Share
|
|
Nov 21
2023
|
Masaru Matsuda Officer |
SELL
Open market or private sale
|
Direct |
1,850
-3.82%
|
$1,850
$1.98 P/Share
|
|
Nov 18
2023
|
Masaru Matsuda Officer |
BUY
Grant, award, or other acquisition
|
Direct |
4,875
+9.14%
|
-
|
|
Oct 24
2023
|
Frazier Life Sciences Viii, L.P. > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
80,000
+0.9%
|
$160,000
$2.5 P/Share
|